Overview
Arginine is a semiessential amino acid that plays a vital role in protein synthesis, metabolism, and nitrogen balance. It is considered conditionally essential because endogenous synthesis may be insufficient during periods of rapid growth, stress, trauma, or illness.
It is a key precursor for nitric oxide, a potent vasodilator involved in the regulation of blood flow and vascular tone. It also participates in the formation of urea, creatine, and polyamines, linking it closely to the urea cycle and detoxification of ammonia. It supports immune function, tissue growth, wound healing, and overall metabolic homeostasis.
Symptoms
Abnormal arginine levels are reflected through systemic metabolic and physiological disturbances. Excess may present with hyperammonemia, lethargy, vomiting, poor appetite, seizures, spasticity, tremors, weakness, poor coordination, failure to thrive, developmental delay, and mild anemia.
Deficiency may cause fatigue, muscle weakness, poor growth, delayed development, impaired wound healing, low immunity with frequent infections, poor vasodilation, irritability, reduced concentration, and increased risk of hyperammonemia. These manifestations are often seen in metabolic disorders, critical illness, or severe catabolic states.
Causes
Altered arginine levels are caused by disturbances in amino acid metabolism, urea cycle function, liver or kidney disease, and increased metabolic demand. Elevated arginine is commonly associated with arginase deficiency and other urea cycle disorders, leading to impaired ammonia detoxification.
Reduced levels may result from protein-energy malnutrition, severe infections, trauma, burns, chronic illness, or increased utilization during stress. Impaired synthesis from citrulline in renal disease and altered hepatic metabolism also contribute to the imbalance.
Risk Factors
Risk factors for abnormal these levels include inherited urea cycle disorders, liver dysfunction, renal disease, critical illness, severe catabolic states, malnutrition, and neonatal metabolic conditions. Infants and children undergoing newborn screening are at higher risk of clinically significant arginine abnormalities.
Patients with cardiovascular disease, immune compromise, or prolonged hospitalization may also show altered arginine metabolism. Improper fasting, delayed sample processing, and analytical variability can affect laboratory interpretation.
Prevention
Prevention focuses on maintaining adequate nutritional intake and early identification of metabolic abnormalities. Balanced dietary protein supports normal arginine availability. Early diagnosis of urea cycle disorders and prompt management help prevent hyperammonemia and neurological damage. Proper laboratory testing with fasting samples, rapid processing, and correct interpretation improves diagnostic accuracy. Timely treatment of underlying metabolic, hepatic, or renal conditions helps maintain normal arginine metabolism and reduces the risk of complications.
